Virtu Financial LLC Bio Path Holdings Inc Transaction History

Virtu Financial LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 27, 2023	BUY	$1.22 - $2.13 $14,532 - $25,372	11,912 New	11,912 $21,000
Q3 2022 Nov 07, 2022	BUY	$3.18 - $66.0 $38,446 - $797,940	12,090 New	12,090 $39,000
Q2 2022 Aug 09, 2022	SELL	$2.83 - $4.02 $28,333 - $40,248	-10,012 Closed	0 $0
Q1 2022 May 17, 2022	BUY	$2.99 - $4.17 $29,935 - $41,750	10,012 New	10,012 $38,000
Q1 2021 May 19, 2021	SELL	$3.63 - $11.77 $120,646 - $391,187	-33,236 Closed	0 $0
Q4 2020 Feb 24, 2021	BUY	$3.21 - $5.26 $106,687 - $174,821	33,236 New	33,236 $116,000
Q2 2019 Aug 13, 2019	SELL	$12.52 - $20.81 $206,091 - $342,553	-16,461 Closed	0 $0
Q1 2019 Apr 12, 2019	BUY	$1.81 - $38.86 $29,794 - $639,674	16,461 New	16,461 $336,000

Ticker BPTH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 7,160,160
Market Cap $7.73M
Description
Bio-Path Holdings, Inc. operates as a clinical and preclinical stage oncology focused RNAi nano particle drug development company in the United States. The company develops products based on DNAbilize, a drug delivery and antisense technology that uses P-ethoxy, which is a deoxyribonucleic acid (DNA) backbone modification intended to protect the...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.